CRISPR THERAPEUTICS AG (CRSP)

SEC filing

CRISPR THERAPEUTICS AG

CRSP · CIK 1674416

4 · Oct 8, 2026 · General Counsel and Secretary KASINGER JAMES R. sold 1,990 Common Shares at $60.04/unit ($119.5K); exercised options for 3,980 shares

General Counsel and Secretary KASINGER JAMES R. sold 1,990 Common Shares at $60.04/unit ($119.5K); exercised options for 3,980 shares

Filed: Oct 8, 2026
Period: Oct 6, 2026
Accession: 0001193125-26-418101
Filer: CRISPR Therapeutics AG

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov